Skip to content
DraconiticResearch
Search Sources API
203,234 studies31 sourcesUpdated 10 min ago
Peer-reviewedCC BY-NC-ND结直肠肛门外科

Current status of research on fecal microbiota transplantation in the postoperative management of inflammatory bowel disease

  • Lin Haojia1
  • Zeng Zhiyu2
  • Wang Mingming2
  • Chen Ye2
  • Wang Anjiang2
  • Cao Xiaocang1
  1. 1Department of Gastroenterology, Tianjin Medical University General Hospital, Tianjin 300052, China
  2. 2Integrative Microecology Clinical Center, Shenzhen Hospital, Southern Medical University, Shenzhen 518000, Guangdong, China
Read full textDOICite

Abstract

For patients with inflammatory bowel disease (IBD), surgery remains a necessary treatment modality for a subset of patients, and gut dysbiosis is a common issue in the postoperative setting. However, current postoperative management protocols for IBD patients lack direct and effective interventions targeting gut dysbiosis. Fecal microbiota transplantation (FMT), which has attracted considerable attention as a gut microecology-modulating therapy, offers a promising avenue for managing postoperative gut dysbiosis in IBD. Drawing on the relevant literature, our team reviews the current status of research on FMT in the postoperative management of IBD, and discusses the advantages, key considerations, and challenges associated with its application.

Related

  1. Microbiome science in fecal microbiota transplantation for inflammatory bowel disease: a WoSCC-centered, three-database bibliometric and knowledge-mapping analysis, 2000–2025
    Zheng Liu, Weijiu Mo, Jingrong Liang +16
    Frontiers in MicrobiologyPeer-reviewedCC BY 4.0MicrobiologyFrontiersCrossref
  2. Acceptability of probiotics, fecal microbiota transplantation, and emerging microbiome-derived therapies in patients with inflammatory bowel diseases: A cross-sectional Survey Study
    Nathan Grellier, Clotilde Policar, Safa Hachicha +10
    Therapeutic Advances in GastroenterologyPeer-reviewedCC BY-NC 4.0Full textGenetics & genomicsHAL
  3. Longitudinal Metaproteomic and Lysine Crotonylation Remodeling Defines Clinical Response to Fecal Microbiota Transplantation in Ulcerative Colitis
    Y. Liu, W. Chen, Y. Yuan +8
    bioRxivPreprintAll rights reservedFull textMicrobiologybioRxiv
  4. From maternal microbial transmission to neonatal gut microbiota restoration: the potential and challenges of maternal fecal microbiota transplantation
    Xia Hu, Guangyu Ma, Jinbiao Han +3
    Frontiers in MicrobiologyPeer-reviewedCC BY 4.0MicrobiologyFrontiersCrossref
  5. Gut microbiota developmental trajectories in min and DLY pigs during lactation and nursery stages and the alleviation of ETEC-induced diarrhea by fecal microbiota transplantation
    Weichun Xie, Zhuoran Li, Jinru Lin +7
    Frontiers in MicrobiologyPeer-reviewedCC BY 4.0Full textZoology & animal behaviourCrossrefDOAJ

Cite

BibTeXRIS
BibTeX
@article{haojia2026current,
  title = {{Current status of research on fecal microbiota transplantation in the postoperative management of inflammatory bowel disease}},
  author = {Lin Haojia and Zeng Zhiyu and Wang Mingming and Chen Ye and Wang Anjiang and Cao Xiaocang},
  journal = {结直肠肛门外科},
  year = {2026},
  month = aug,
  doi = {10.19668/j.cnki.issn1674-0491.2026.04.006},
  url = {https://doi.org/10.19668/j.cnki.issn1674-0491.2026.04.006},
  note = {CC BY-NC-ND},
}
RIS
TY  - JOUR
TI  - Current status of research on fecal microbiota transplantation in the postoperative management of inflammatory bowel disease
AU  - Lin Haojia
AU  - Zeng Zhiyu
AU  - Wang Mingming
AU  - Chen Ye
AU  - Wang Anjiang
AU  - Cao Xiaocang
PY  - 2026
DA  - 2026/08/01
JO  - 结直肠肛门外科
DO  - 10.19668/j.cnki.issn1674-0491.2026.04.006
UR  - https://doi.org/10.19668/j.cnki.issn1674-0491.2026.04.006
AB  - For patients with inflammatory bowel disease (IBD), surgery remains a necessary treatment modality for a subset of patients, and gut dysbiosis is a common issue in the postoperative setting. However, current postoperative management protocols for IBD patients lack direct and effective interventions targeting gut dysbiosis. Fecal microbiota transplantation (FMT), which has attracted considerable attention as a gut microecology-modulating therapy, offers a promising avenue for managing postoperative gut dysbiosis in IBD. Drawing on the relevant literature, our team reviews the current status of research on FMT in the postoperative management of IBD, and discusses the advantages, key considerations, and challenges associated with its application.
SN  - 1674-0491
ER  -